| Human MFAP4 Protein (LTP10475) |
| LTP10475 |
| 100ug |
|
$406 In stock |
| Microfibril-associated glycoprotein 4 (MFAP4) is an extracellular matrix protein belonging to the fibrinogen-related protein superfamily. MFAP4 is produced by vascular smooth muscle cells and is highly enriched in the blood vessels of the heart and lung, where it is thought to contribute to the structure and function of elastic fibers. Genetic studies in humans have implicated MFAP4 in the pathogenesis of Smith-Magenis syndrome, in which patients present with multiple congenital abnormalities and mental retardation, as well as in the severe cardiac malformation left-sided congenital heart disease. |
| Recombinant Human MFAP4 Protein is expressed from Expi293 with His tag and Flag tag at the N-terminal. It contains Val22-Ala255. |
| MFAP4 |
| Human |
| P55083-1 |
| Val22-Ala255 |
| The protein has a predicted MW of 28.6 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on the Tris-Bis PAGE result. |
| Immobilized Human MFAP4, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Anti-MFAP4 Antibody, hFc Tag with the EC50 of 7.6ng/ml determined by ELISA. See testing image for detail. |
| N-His-Flag |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| |